| RS1085307407 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307408 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307409 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS1085307410 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307411 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307412 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307413 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS1085307414 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307415 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1085307416 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1085307417 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307418 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1085307419 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307420 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307421 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1085307422 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS1085307423 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307424 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307425 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307426 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307427 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307428 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1085307429 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1085307430 |
ENG
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307431 |
ENG
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1085307432 |
ENG
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1085307433 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307434 |
ENG
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307435 |
ENG
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS1085307436 |
ENG
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307438 |
KCNK3
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307439 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS1085307441 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS1085307442 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS1085307443 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS1085307444 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS1085307445 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS1085307446 |
CWC27
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome, Retinitis pigmentosa |
| RS1085307447 |
CWC27
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome, Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome |
| RS1085307449 |
TMEM260
|
Health Risk |
Pathogenic |
Structural heart defects and renal anomalies syndrome, Structural heart defects and renal anomalies syndrome |
| RS1085307450 |
PLD1
|
Health Risk |
Pathogenic |
Cardiac valvular defect, developmental |
| RS1085307451 |
DHX30
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with severe motor impairment and absent language, Inborn genetic diseases |
| RS1085307452 |
DEPDC5
|
Health Risk |
Pathogenic |
— |
| RS1085307454 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1085307455 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1085307457 |
EFTUD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1085307459 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1085307461 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1085307462 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS1085307463 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1085307465 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS1085307466 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1085307468 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1085307470 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1085307471 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1085307472 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, Inborn genetic diseases |
| RS1085307477 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1085307478 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1085307479 |
CALM1
|
Health Risk |
Pathogenic |
Long QT syndrome 14, Catecholaminergic polymorphic ventricular tachycardia 4 |
| RS1085307480 |
WAC
|
Health Risk |
Pathogenic/Likely pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, Intellectual disability |
| RS1085307481 |
SOX2
|
Health Risk |
Pathogenic |
— |
| RS1085307482 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1085307484 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1085307486 |
TUBB
|
Health Risk |
Likely pathogenic |
— |
| RS1085307490 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1085307492 |
SDHAF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex 2 deficiency, nuclear type 2 |
| RS1085307496 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aneurysm-osteoarthritis syndrome |
| RS1085307497 |
COQ8A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307499 |
GJC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the nervous system, Hypomyelinating leukodystrophy 2 |
| RS1085307500 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1085307502 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1085307505 |
AMER1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307506 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1085307508 |
FOXC1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307511 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1085307512 |
POU3F4
|
Health Risk |
Pathogenic |
— |
| RS1085307513 |
SIX3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307518 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1085307520 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS1085307522 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1085307524 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1085307527 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307528 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1085307529 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS1085307531 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1085307534 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1085307535 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1085307537 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, 8 conditions |
| RS1085307541 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307542 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307544 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1085307547 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Complex neurodevelopmental disorder |
| RS1085307550 |
ECHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS1085307553 |
RAF1
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS1085307555 |
TWIST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS1085307556 |
SMARCA4
|
Health Risk |
Pathogenic |
— |
| RS1085307560 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1085307562 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1085307563 |
XYLT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 2, Desbuquois dysplasia 2 |
| RS1085307564 |
EP300
|
Health Risk |
Likely pathogenic |
— |